How to diagnose multiple sclerosis and what are the pitfalls

Internal Medicine Journal

Volumn 39, Issue 12, 2009, Pages 792-799

  Shaw, C ^a   Chapman, C ^a   Butzkueven, H ^b  

^a GEELONG HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinically isolated syndrome; Differential diagnosis; Magnetic resonance imaging; Multiple sclerosis; Pitfalls; Practical guide

Indexed keywords

ATAXIA; BLADDER DYSFUNCTION; BRAIN BIOPSY; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EVOKED VISUAL RESPONSE; FOLLOW UP; HUMAN; INTERNUCLEAR OPHTHALMOPLEGIA; MIGRAINE; MULTIPLE SCLEROSIS; MYELITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OPTIC NEURITIS; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RELAPSE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TRIGEMINUS NEURALGIA;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MULTIPLE SCLEROSIS;

EID: 73649107629     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02081.x     Document Type: Review

References (19)

1. Cook SD. Handbook of Multiple Sclerosis, 4th edn. New York : Taylor & Francis 2006.
2. Compston A. McAlpine's Multiple Sclerosis, 4th edn. London : Elsevier 2006.
3. Nilsson P, Larsson EM, Maly-Sundgren P, Perfekt R, Sandberg-Wollheim M. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up. J Neurol 2005 252 : 396 402.
4. O'Connor P. Canadian Multiple Sclerosis Working Group. Key issues in the diagnosis and treatment of multiple sclerosis. An overview. Neurology 2002 59 : S1 33.
5. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. [see comment]. Neurology 2003 61 : 1528 1532.
6. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005 4 : 281 288. (Pubitemid 40545039)
7. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. [see comment]. Ann Neurol 2005 58 : 840 846.
8. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. [see comment]. Neurology 1996 46 : 907 911.
9. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. [see comment]. N Engl J Med 2000 343 : 938 952.
10. Lee KH, Hashimoto SA, Hooge JP, Kastrukoff LF, Oger JJ, Li DK et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991 41 : 657 660.
11. Korteweg T, Tintore M, Uitdehaag B, Rovira A, Frederiksen J, Miller D et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006 5 : 221 227. (Pubitemid 43238345)
12. Barkhof F, Filippi M, Miller DH, Scheltens P, Campi A, Polman CH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997 120 : 2059 2069.
13. Bot JC, Barkhof F, Lycklama à Nijeholt G, van Schaardenburg D, Voskuyl AE, Ader HJ et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002 223 : 46 56.
14. Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis. Neurologist 2007 13 : 57 72.
15. Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR. Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine 2000 79 : 57 68.
16. Bot JC, Barkhof F, Polman CH, Lycklama a Nijeholt GJ, de Groot V et al. Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004 62 : 226 233.
17. Anonymous. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Optic Neuritis Study Group. [see comment]. Neurology 1997 49 : 1404 1413.
18. Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT et al. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. [see comment]. Arch Ophthal 2003 121 : 944 949.
19. Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 2006 180 : 17 28.